These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 14608510)

  • 1. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E
    J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.
    Lobentanz IS; Asenbaum S; Vass K; Sauter C; Klösch G; Kollegger H; Kristoferitsch W; Zeitlhofer J
    Acta Neurol Scand; 2004 Jul; 110(1):6-13. PubMed ID: 15180801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of performance scales for disability assessment in multiple sclerosis.
    Marrie RA; Goldman M
    Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of fatigue in multiple sclerosis.
    Bergamaschi R; Romani A; Versino M; Poli R; Cosi V
    Funct Neurol; 1997; 12(5):247-51. PubMed ID: 9439942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disturbances in relation to fatigue in major depression.
    Ferentinos P; Kontaxakis V; Havaki-Kontaxaki B; Paparrigopoulos T; Dikeos D; Ktonas P; Soldatos C
    J Psychosom Res; 2009 Jan; 66(1):37-42. PubMed ID: 19073291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
    Sauter C; Zebenholzer K; Hisakawa J; Zeitlhofer J; Vass K
    Mult Scler; 2008 May; 14(4):500-5. PubMed ID: 18208883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue and quality of life in pediatric multiple sclerosis.
    MacAllister WS; Christodoulou C; Troxell R; Milazzo M; Block P; Preston TE; Bender HA; Belman A; Krupp LB
    Mult Scler; 2009 Dec; 15(12):1502-8. PubMed ID: 19965517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
    Lin X; Tench CR; Morgan PS; Niepel G; Constantinescu CS
    J Neurol Sci; 2005 Oct; 237(1-2):13-9. PubMed ID: 16109428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
    Kaminska M; Kimoff RJ; Benedetti A; Robinson A; Bar-Or A; Lapierre Y; Schwartzman K; Trojan DA
    Mult Scler; 2012 Aug; 18(8):1159-69. PubMed ID: 22183937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue].
    Gerhard R; Bosse A; Uzun D; Orth M; Kotterba S
    Med Klin (Munich); 2005 Nov; 100(11):704-9. PubMed ID: 16328177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paced visual serial addition test in multiple sclerosis.
    Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
    Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
    J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.